beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Arrhenoblastoma

En Español (Spanish Version)

Definition | Causes | Risk Factors | Symptoms | Diagnosis | Treatment | Prevention

Definition

An arrhenoblastoma is a rare type of ovarian tumor. This tumor primarily secretes the male sex hormone, testosterone, and rarely the female sex hormone, estrogen.

Arrhenoblastomas are generally benign, meaning they do not normally spread beyond the ovary.

Arrhenoblastoma

Ovarian Cancer

Copyright © Nucleus Medical Media, Inc.

Causes

The cause of arrhenoblastoma is unknown.

Risk Factors

Arrhenoblastomas are most common in young women between the ages of 20 and 30 years of age. However, they can occur at any age, including in toddlers, young girls, and postmenopausal women.

Arrhenoblastoma mare also be a rare complication of pregnancy.

Symptoms

In many cases, infrequent menstrual periods or cessation of menstrual periods is the only symptom.

In up to one in three patients, arrhenoblastoma is accompanied by masculinization, including any of the following:

Diagnosis

You will be asked about your symptoms and medical history. A physical exam will be done.

Your bodily fluids may be tested. This can be done blood tests of hormone levels.

Images may be taken of your bodily structures. This can be done with ultrasound.

Pelvic Ultrasound

Pelvic Ultrasound

Copyright © Nucleus Medical Media, Inc.

Treatment

Treatment involves surgery to remove one or both ovaries. This procedure is usually successful in returning normal menstruation (in premenopausal women) and ceasing masculinization. If the tumor is late stage and particularly aggressive (which is rare), radiation therapy , chemotherapy , or both, in addition to surgery, may be needed.

Prevention

There are no known ways to prevent ovarian cancer of any kind, as the cause is unknown.

 

RESOURCES:

CANADIAN RESOURCES:

References:

  • Chen F, Sheu B, et al. Sertoli-leydig cell tumor of the ovary. J Formos Med Assoc. Available at: http://cat.inist.fr/?aModele=afficheN&cpsidt=17460145. Accessed October 29, 2014.
  • Choong S, Fuller P, et al. Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant. J Clin Endocrinol Metab. 2002;87:49-56.
  • Colombo N, Parma G, et al. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;20:2944-2951.
  • Leydig cell tumor. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated February 28, 2011. Accessed October 29, 2014.
  • McCluggage WG, McKenna M, et al. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord stromal tumor. Int J Gyn Pathol. 2007;26:322-327.
  • Sachdeva P, Arora R, et al. Cell tumor: a rare ovarian neoplasm. Gynecologic Endocrinology. 2008;24(4):230-234.
  • Sex cord-stromal tumors. Johns Hopkins Pathology website. Available at: http://ovariancancer.jhmi.edu/stromal.cfm. Updated June 25, 2001. Accessed October 29, 2014.

Search Your Health